	Natural and synthetic compounds targeting ferroptosis in esophageal squamous cell carcinoma: Research progress and application potential. Eur J Med Chem Wu N, Wang G, Wang J, Wu M, Wang X, Ma J, He W. PMID: 41349319 [PubMed - as supplied by publisher]
	Trajectories of postoperative nutritional risk changes in patients with oesophageal cancer and their relationship with symptom recovery-a multicentre longitudinal study. Support Care Cancer Li S, Qin Y, Chen J, Miao A, Li S. PMID: 41348216 [PubMed - indexed for MEDLINE]
	A Commentary on "Neoadjuvant chemotherapy with albumin-bound paclitaxel plus cisplatin and capecitabine for locally advanced esophageal squamous cell carcinoma: a phase 2 clinical trial". Int J Surg Jin Z, Gao L, Song Y. PMID: 41347964 [PubMed - as supplied by publisher]
	Minimally invasive esophagectomy drives a decade-long decline in upper mediastinal recurrence after esophageal cancer surgery: a real-world, single-center cohort study. Front Oncol Zhang S, Hu A, Sun J, Wei Y, Zhang J, Zhong K, Cai H, Wang G. PMID: 41347076 [PubMed]
	Construction and validation of a transmembrane 4 superfamily-related genes prognostic model for esophageal squamous cell carcinoma. Front Oncol Hao X, Ding H, Zhu H, Gong X, Chang Y, Liu C, Hou S. PMID: 41347075 [PubMed]
	Research trends in neoadjuvant therapy for esophageal cancer: a bibliometric and meta-analysis. Front Immunol Wang H, Zhang J, Yang J, Chang H. PMID: 41346615 [PubMed - indexed for MEDLINE]
	Addition of immunotherapy to perioperative chemotherapy for resectable gastric and gastroesophageal junction cancer: a meta-analysis of phase 2/3 trials. Front Immunol Lin Y, Liao Y, Shen J. PMID: 41346601 [PubMed - indexed for MEDLINE]
	PERi-operative selective decontamination of the digestive tract to prevent severe infectious complications after Esophageal Resection: study protocol of the PERSuaDER-trial, a multicenter randomized controlled trial in patients with primary resectable esophageal carcinoma. Trials Grootenhuis JGA, Seurs W, Garms LM, de Vries M, Ubels S, van Werkhoven HC, Rosman C, Schouten JA, Klarenbeek BR, Van Veer H. PMID: 41345690 [PubMed - as supplied by publisher]
	Ivor Lewis minimally invasive oesophagectomy versus McKeown approach: short-term benefits and mid-term equivalence in a randomized trial for oesophageal squamous cell carcinoma. Surg Endosc Xiu R, An R, Shan L, Zhang W, Cong B, Zhao X, Zhao Y. PMID: 41345532 [PubMed - as supplied by publisher]
	Risk factors of postoperative complications and prognostic factors in patients undergoing esophagectomy reconstructed with colonic interposition. Dis Esophagus Takahashi N, Okamura A, Terayama M, Kato T, Ishida H, Kanamori J, Imamura Y, Taketomi A, Watanabe M. PMID: 41343727 [PubMed - indexed for MEDLINE]
	Recent advances in risk stratification of patients with Barrett's esophagus. Dis Esophagus Perananthan V, Iyer PG. PMID: 41343724 [PubMed - indexed for MEDLINE]
	[Identification of incomplete response following neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma : Results of the preSINO study]. Chirurgie (Heidelb) Schiffmann LM, Bruns CJ. PMID: 41342916 [PubMed - as supplied by publisher]
	The mediating role of inflammation in cancer risk among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study. Int J Surg Bu J, Mi N, Liang Z, Xie P, Long C, Yang M, Yuan J, Xia B, Liu A, Xiang S, He Q. PMID: 41342547 [PubMed - as supplied by publisher]
	Advancing immunotherapy for esophageal cancer: decoding the roles of PD-L1, TME, and tumor-intrinsic biomarkers. Front Immunol Ma J, Wu D, Liu Y, Zhang G. PMID: 41341591 [PubMed - indexed for MEDLINE]
	A phase II study of trifluridine/tipiracil in combination with ramucirumab in advanced, refractory gastric, or gastroesophageal junction adenocarcinomas. Oncologist Kim DW, Kim RD, Jimenez MM, Kim Y, Mehta R. PMID: 41335458 [PubMed - indexed for MEDLINE]
	Comparative Efficacy and Safety of Tislelizumab in Second-Line Esophageal Squamous Cell Carcinoma: Systematic Literature Review and Simulated Treatment Comparisons. Adv Ther Ajani JA, Wang K, Nikolaidis GF, Coaquira Castro J, Augusto Novis de Figueiredo M, Sun JM, Soulanis K, Tasoulas A, Zhan L. PMID: 41335329 [PubMed - as supplied by publisher]
	Preoperative Short-Term Nutrition and Exercise Trial Program for Patients with Esophageal Cancer: A Randomized Clinical Trial: Thoracic Oncology. Ann Surg Oncol Kawata S, Hiramatsu Y, Honke J, Takashima S, Shirai Y, Shibata Y, Sakai Y, Haneda R, Soneda W, Murakami T, Booka E, Matsumoto T, Morita Y, Kikuchi H, Yamauchi K, Takeuchi H. PMID: 41335173 [PubMed - as supplied by publisher]
	Nutritional support and immunonutrition in esophageal cancer - From perioperative care to long-term survivorship: A review. Biomol Biomed Hussein M, Mohamed T, Mubarak FA, Morad F, Naser M, Humaira A, Amina H, Khan M. PMID: 41334710 [PubMed - as supplied by publisher]
	Validation of a blood test for multi-cancer risk stratification in a lung cancer screening cohort. medRxiv Fahrmann JF, Irajizad E, Rudsari H, Vykoukal J, Toumazis I, Khorami-Sarvestani S, Ansari S, Yang J, Kettner N, Dennison JB, Ostrin E, Hanash S. PMID: 41332848 [PubMed]
	Study protocol of a randomized controlled phase II trial comparing nivolumab, ipilimumab plus radiotherapy versus nivolumab plus ipilimumab for advanced or recurrent esophageal cancer: Japan Clinical Oncology Group study JCOG2311 (ART NOUVEAU). BMC Cancer Sakanaka K, Sasaki K, Tsushima T, Machida R, Hamai Y, Watanabe A, Kawabata K, Matsuda S, Kato K, Fukuda H, Takeuchi H, Japan Esophageal Oncology Group of the Japan Clinical Oncology Group. PMID: 41331921 [PubMed - as supplied by publisher]

Articles 1 - 20 / 37800

Page 1 of 1890



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy